Valeant Pharmaceuticals International has completed the change of its company name to Bausch Health Companies, as previously announced in May 2018. The new name is taken from its subsidiary, Bausch + Lomb, an eye-care company, which Valeant acquired in 2013.

“Choosing Bausch Health as our new corporate name is very meaningful because the Bausch name has long been a highly respected name in the healthcare space, synonymous for 165 years with innovation and an unwavering dedication to improving people’s lives,” said Joseph C. Papa, Chairman and Chief Executive Officer, Bausch Health Companies in a July 13, 2018 company statement.

Bausch Health Companies will begin trading as “BHC” on the New York Stock Exchange and Toronto Stock Exchange on July 16, 2018. As part of the name change, Bausch Health Companies has unveiled a new corporate brand visual identity, and on July 16, 2018, will launch a new corporate website.

All entities that have separate established brands will continue to operate under the corporate umbrella using their existing names.

Source: Bausch Health Companies